CD14 Blockade Attenuates Arrhythmogenic Cardiomyopathy
Vinay R. Penna, Emily A. Shiel, Waleed Farra…·Kory J. Lavine
This study shows that blocking CD14 reduces arrhythmogenic cardiomyopathy in mice by decreasing inflammation and fibrosis.
Author
Florida State UniversityORCID 0000-0003-1675-5945Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Vinay R. Penna, Emily A. Shiel, Waleed Farra…·Kory J. Lavine
This study shows that blocking CD14 reduces arrhythmogenic cardiomyopathy in mice by decreasing inflammation and fibrosis.
Vinay R. Penna, Junedh Amrute, Morgan Engel…·Stephen P. Chelko
Human arrhythmogenic cardiomyopathy hearts harbor a lesion niche of POSTN fibroblasts and NLRP3+ inflammatory macrophages; IL-1β neutralization in Dsg2-mutant mice reduced fibrosis, dysfunction, and ventricular ectopy.
Emily Shiel, Gallage H. D. Nipun Ariyaratne, Waleed Farra…·Stephen P. Chelko
This study shows that PAD4-dependent NETosis and MPO contribute to inflammation, fibrosis, and arrhythmias in ACM, with targeting these pathways improving cardiac function.
Maicon Landim-Vieira, Vivek Jani, Emily Shiel…·Stephen P. Chelko
This study shows that DSG2 deficiency causes cardiac dysfunction by impairing Z-disc and intercalated disc mechanotransduction, leading to structural and functional cardiac defects.
Tooyib A. Azeez, Clifford J. Pierre, Colin M. Ihrig…·Justin D. La Favor
Ann Marie Centner, Abigail E. Cullen, Leila Khalili…·Gloria Salazar
This study investigates sex-specific effects of cigarette smoke and nicotine on cardiovascular function, atherosclerosis, and inflammation in mice, finding sex differences in lipid profiles, plaque composition, and inflammatory markers.